Skip to main content
Clinical Trials/PACTR202102689928613
PACTR202102689928613
Other
Phase 2

Dietary supplementation with a synbiotic to improve growth in early life in Senegal: an individually randomised, 2 arm, open-label, controlled study of a synbiotic in infants in Kaffrine District, Senegal.

iverpool School of Tropical Medicine0 sites708 target enrollmentNovember 12, 2020

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
iverpool School of Tropical Medicine
Enrollment
708
Status
Other
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 12, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
iverpool School of Tropical Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) singleton newborn
  • 2\) birth weight (BW) or current weight (if BW not known) 2000g or more
  • 3\) well infant who is breastfed and has taken at least one breastfeed well
  • 4\) age 1\-3 days
  • 5\) informed consent secured from mother/carer
  • 6\) Infants of HIV positive women without known immunosuppression

Exclusion Criteria

  • 1\) multiple pregnancy (e.g. twin/triplets)
  • 2\) suspicion or presence of any acute illness (e.g. fever, receiving treatment with antibiotics)
  • 3\) congenital abnormality that might be life\-threatening or impair growth
  • 4\) infant with potential contraindication to synbiotic (e.g. suspected immune suppression; cardiac abnormality)
  • 5\) mother unlikely to stay in study area for the duration of the study
  • 6\) any health staff or study staff concerns regarding safety to participate in the trial

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Probiotic preparation, VSL#3 as a support pharmaceutical therapy in cirrhotic patients for the treatment of minimal hepatic encephalopathy (MHE)Health Condition 1: null- Cirrhotic patients with Minimal Hepatic encephalopathy
CTRI/2008/091/000268CD Pharma India Pvt Ltd
Completed
Not Applicable
The Effects of Synbiotics, Branched Chain Amino Acids on Hepatic EncephalopathyHepatic encephalopathy in patients with cirrhosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDiet and Nutrition - Other diet and nutrition disorders
ACTRN12610001021066Royal Prince Alfred Hospital80
Active, not recruiting
Not Applicable
utrient supplementation to improve the behavior of children with Autism Spectrum DisorderAutism Spectrum Disorder
RBR-5hs6ry4niversidade Federal de Santa Maria
Completed
Not Applicable
The effects of synbiotic supplementation on dietary intake?nutritional status, quality of life, serum Matrix Metalloproteinase enzymes,serum inflammatory markers levels(TNFa,IL-6) and side effects of treatment in rectal cancer patients undergoing neoadjuvant chemoradiotherapyRectal cancer.Malignant neoplasm of rectum
IRCT201503181197N18utritional Research Center,Tabriz University of Medical Sciences46
Recruiting
Phase 3
The effect of probiotic supplementation on pregnancy outcomes in mothers with mild preeclampsiamild preeclampsia.Mild to moderate pre-eclampsiaO14.0
IRCT20110606006709N20Tabriz University of Medical Sciences128